Erin McEvoy

Royal Emerald Pharmaceuticals, a leading cannabis pharmaceutical company, announced it has received four licenses from the DEA to grow, research, develop, and manufacture alternative drugs derived from cannabis and other botanicals.

Yissum, the Technology Transfer Company at Hebrew University of Jerusalem as well as the university's Multidisciplinary Center for Cannabinoid Research (MCCR) recently announced a new partnership with TechforCann Europe Accelerator to strengthen the medical cannabis industry in Europe.